Christopher Wilfong

Chief Operating Officer

Christopher is an Operating Partner at Two River, and has been a co-founder and held interim management roles in several Two River portfolio companies including Kite Pharma, Inc., Arno Therapeutics, Inc., and Nile Therapeutics, Inc. (acquired by Capricor Therapeutics). Prior to Two River, Christopher was a Director at Trustbridge Partners, a China-based growth equity firm, where he led the US investment team and negotiated multiple US-China joint ventures and strategic partnerships in the healthcare and media industries. Prior to that, he was a Consultant at Bain & Company. Christopher received his Master of Business Administration from the MIT Sloan School of Management, and his Bachelor of Science in Economics from the Wharton School of the University of Pennsylvania.